Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural ropivacaine plus BiPAP versus intravenous morphine/ketorolac plus facemask oxygen in chest trauma with lung contusion
IRCT20190922044842N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Aug 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in chest injury and Lung Contusion comparing Thoracic epidural ropivacaine + BiPAP with Intravenous morphine + ketorolac + facemask oxygen (2 arms). Primary endpoints: Pain control, Need for intubation and 1 more. Started Aug 2019; status: completed.
02
Drugs
ropivacainemorphineketorolac
03
Conditions
chest injuryLung Contusion
Beyond the preview
Go deeper on IRCT20190922044842N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190922044842N1.